PLATFORM · L7 PLM

L7 PLM

One governed record for lifecycle CMC development, whether you're a Pharma or Biotech sponsor working with many CRDMOs or a CRDMO serving many sponsors.

what is it

Your PPM tool plans the portfolio. L7 PLM governs the execution underneath it.

L7 PLM is a collaborative application on L7|ESP® that connects Pharma and Biotech CMC development teams with their CRDMO partners, in both directions. Sponsors govern every CRDMO relationship in one record, and CRDMOs do the same across every sponsor they serve. Teams get one governed place to create, find, and manage the documents behind every project, across the entire portfolio. Working with L7 MES, L7 LIMS, and L7 Notebooks, L7 PLM accelerates tech transfer and carries each molecule through its lifecycle stage gates, from early phase to late phase.

To bridge the gap between unstructured files and actionable intelligence, L7 PLM can use L7|SYNAPSE™ to take executed batch records, certificates of testing, and stability study reports and convert this document-centric data into structured, submission-ready datasets. Every document, campaign batch, stability study, and partner upload is linked in L7|ESP’s relationship graph. A program leader can trace a result back to its study, its batch, and the CRDMO that submitted it, while partners have clear, scoped visibility into what is required.

THE CHALLENGE

When a CRDMO misses a stability pull, the sponsor finds out late.

CMC development programs run on collaborative work from many hands: internal scientists at Pharma and Biotech organizations, alongside their external CRDMO partners. The evidence behind each milestone often ends up scattered across inboxes, shared drives, and general-purpose apps. Without a reliable bi-directional flow of information, when a CRDMO misses a stability pull, the sponsor finds out late and chases it by hand. Program leaders spend their time reconstructing status instead of acting on it, and the legacy PLM systems that once held this together are reaching end of life.

the foundation of a digital thread

Traceability starts with a single governed, bi-directional record.

L7 PLM builds it layer by layer on L7|ESP, so every result can be traced back to its batch, its study, and the CRDMO that submitted it.

L7 PLM - the foundation of a digital thread illustration

L7 PLM builds it layer by layer on L7|ESP, so every result can be traced back to its batch, its study, and the CRDMO that submitted it.

OUTCOME

What changes with L7 PLM.

Less than 1 min

to create a full stability study with every pull scheduled.

Portfolio-wide traceability

to track every molecule and asset across early phase to late phase development.

Structured data generation

to transform raw, document-centric partner deliverables into submission-ready datasets via L7|SYNAPSE.

Every version

records who published it, when, and why, and locks once published.

Every pull

carries an audit-ready status, with bi-directional reminders that escalate to QA.

Every result

traces back to its batch, its study, and the CRDMO partner that submitted it.

COMPLIANCE AND SECURITY

Built for regulated collaboration.

21 CFR Part 11 e-signatures.

Complete audit trail of who, when, and why, including study cancellations.

Complete audit trail of who, when, and why, including study cancellations.

Proven in a regulated enterprise.

L7 PLM went live at a global pharmaceutical company, initially replacing an end-of-life PLM system for early-phase development. The rollout spanned four organizations and passed enterprise cybersecurity, privacy, and identity reviews, including MFA access for external CRDMO users.

L7 PLM replaced our legacy PLM for creating, finding, and managing early-phase documents, and is meant to eventually connect into a knowledge layer for AI use cases.

Director, IT Solutions, top-5 global pharmaceutical company

RESOURCES

Dive deeper into the platform.

Explore the L7 Resource Center

Ready to take the next step?

Book a personalized demo and see how L7|ESP can accelerate your science.

BOOK A DEMO